One study demonstrated that Axl inhibition increases the number of tumor-infiltrating CD8+ T-cells [92], while other studies demonstrated that Axl inhibition has no effect on the number of tumor-infiltrating CD8+ T-cells [55,77,87] (Table 2). The gene discussed is AXL; the disease is neoplasm.